Orforglipron Pill Shows Promise in Weight Maintenance
Update: 2025-12-18
Description
Eli Lillys experimental obesity pill, orforglipron, shows promise in maintaining weight loss after stopping injectable treatments. The pill, which is easier to take and more affordable, could be a game-changer for weight management. Lilly has requested FDA approval for the pill as a starting treatment and maintenance therapy.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
